Jakub Swiercz

Biography

Jakub’s team is responsible for assay development for in vitro pharmacology, and the characterization of the mechanisms of action for new targets. Before joining iTeos in 2015, Jakub led a team of scientists at the Max-Planck-Institute. His group was responsible for the design and execution of HTS in the fields of tumor development and metastasis. Jakub holds a MSc in Biotechnology from the Intercollegiate Faculty of Biotechnology of the University of Gdansk/Medical University of Gdansk and a Ph.D. in pharmacology from the University of Heidelberg. He has authored 21 peer-reviewed publications and is the inventor of two patent applications.  

Research Interest

Biotechnology